BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8451832)

  • 21. Evaluation of vaccines for atrophic rhinitis--a comparison of three challenge models.
    Magyar T; King VL; Kovács F
    Vaccine; 2002 Mar; 20(13-14):1797-802. PubMed ID: 11906767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Atrophic rhinitis of swine: neutralization of the toxin of Pasteurella multocida].
    Schimmelpfennig H
    Dtsch Tierarztl Wochenschr; 1990 May; 97(5):195-6. PubMed ID: 2364889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effect of Pasteurella multocida cell-free antigen and toxoid against challenge with toxigenic strains of pasteurella multocida in mice.
    Uchida C; Kimura Y; Kubota S; Sasaki O
    J Vet Med Sci; 2003 Jun; 65(6):737-40. PubMed ID: 12867737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Aerogenous immunostimulation of weaner swine against experimentally induced respiratory infections with Pasteurella multocida].
    Müller G; Köhler H; Stache B; Heilmann P; Kludas KH
    Zentralbl Veterinarmed B; 1993 Aug; 40(6):423-9. PubMed ID: 8284955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical Pasteurella strains producing a toxin similar to the dermonecrotic toxin of Pasteurella multocida subspecies multocida.
    Kamp EM; ter Laak EA; de Jong MF
    Vet Rec; 1990 Apr; 126(17):434-7. PubMed ID: 2111955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colonisation by Pasteurella multocida in atrophic rhinitis of pigs and immunity to the osteolytic toxin.
    Chanter N; Rutter JM
    Vet Microbiol; 1990 Nov; 25(2-3):253-65. PubMed ID: 2149226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogens of Pasteurella.
    Confer AW
    Vet Microbiol; 1993 Nov; 37(3-4):353-68. PubMed ID: 8116191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigenicity of partial fragments of recombinant Pasteurella multocida toxin.
    Lee J; Woo HJ
    J Microbiol Biotechnol; 2010 Dec; 20(12):1756-63. PubMed ID: 21193834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-protection of recombinant Pasteurella multocida toxin proteins against atrophic rhinitis in mice.
    Wu MC; Lo YT; Wu HC; Wang HY; Chu CY
    Res Vet Sci; 2021 Jul; 137():138-143. PubMed ID: 33975192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccine potential of an attenuated Pasteurella multocida that expresses only the N-terminal truncated fragment of P. multocida toxin in pigs.
    Kim T; Son C; Lee J; Kim K
    Can J Vet Res; 2012 Jan; 76(1):69-71. PubMed ID: 22754098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody reactions after aerogenous or subcutaneous immunization of pigs with Pasteurella multocida antigens.
    Müller G; Köhler H; Diller R; Erler W
    Vaccine; 2000 Nov; 19(7-8):751-7. PubMed ID: 11115696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experience in the control of infectious atrophic rhinitis of swine].
    Nitsmane AK
    Veterinariia; 1969 Feb; 46(2):31-2. PubMed ID: 5392388
    [No Abstract]   [Full Text] [Related]  

  • 33. Dermonecrotic activity of Pasteurella multocida strains isolated from pigs in Japanese field.
    Sawata A; Nakai T; Tuji M; Kume K
    Nihon Juigaku Zasshi; 1984 Apr; 46(2):141-8. PubMed ID: 6748440
    [No Abstract]   [Full Text] [Related]  

  • 34. Protection of piglets against atrophic rhinitis by vaccinating the sow with a vaccine against Pasteurella multocida and Bordetella bronchiseptica.
    Riising HJ; van Empel P; Witvliet M
    Vet Rec; 2002 May; 150(18):569-71. PubMed ID: 12019649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The detection of Pasteurella multocida toxin using a commercially available ELISA].
    Weber A; Wachowitz R; Singer H; Heil-Franke G
    Berl Munch Tierarztl Wochenschr; 1993 Oct; 106(10):328-30. PubMed ID: 8250823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of nasal turbinate atrophy in germ-free pigs, using Pasteurella multocida as well as bacterium-free crude and purified dermonecrotic toxin of P multocida.
    Kamp EM; Kimman TG
    Am J Vet Res; 1988 Nov; 49(11):1844-9. PubMed ID: 3247905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the dermonecrotic toxin by Bordetella bronchiseptica is not necessary for predisposing to infection with toxigenic Pasteurella multocida.
    Brockmeier SL; Register KB
    Vet Microbiol; 2007 Dec; 125(3-4):284-9. PubMed ID: 17624695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination against atrophic rhinitis: effect on clinical symptoms, growth rate and turbinate atrophy.
    Baalsrud KJ
    Acta Vet Scand; 1987; 28(3-4):305-11. PubMed ID: 3454542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of gene expression of Toll-like receptors and cytokines between Piau and Commercial line (Landrace×Large White crossbred) pigs vaccinated against Pasteurella multocida type D.
    Sousa KRS; Ribeiro AMF; Dantas WMF; Oliveira LL; Gasparino E; Guimarães SEF
    Res Vet Sci; 2017 Oct; 114():273-280. PubMed ID: 28554143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The aetiological significance of Bordetella bronchiseptica and Pasteurella multocida in atrophic rhinitis of swine.
    Pedersen KB; Barfod K
    Nord Vet Med; 1981 Dec; 33(12):513-22. PubMed ID: 7335484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.